Mesothelin Tests in Patients Can Help Monitor Mesothelioma Disease Progression

MHN Staff

Researchers may have confirmed a quick, effective and minimally invasive tumor tracking test for pleural mesothelioma. A simple blood test may soon accompany the standard CT scans to accurately detect tumors and allow doctors to quickly respond with appropriate treatments. Mesothelin Testing in Mesothelioma Patients Researchers have been investigating the connection between mesothelin blood levels

Clinical Trial Recruiting Mesothelioma Patients to Undergo Immunotherapy Treatment MesoPher

MHN Staff

Amphera, a Dutch biotechnology company has been developing a new immunotherapy for pleural mesothelioma—MesoPher. In March 2019, the company announced they have recruited the first patients to participate in their Phase 2/3 study to investigate MesoPher as a second-line treatment option for pleural mesothelioma. Currently, chemotherapy using a mixture of Alimta® (pemetrexed) and cisplatin drugs